切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2021, Vol. 07 ›› Issue (04) : 331 -338. doi: 10.3877/cma.j.issn.2096-1537.2021.04.009

重症医学研究

2000年至2020年脓毒症心肌病领域的研究进展:基于知识可视化分析
肖文艳1, 刘瑜2, 陆宗庆1, 陶干1, 张金1, 张洋1, 华天凤1, 杨旻1,()   
  1. 1. 230601 合肥,安徽医科大学第二附属医院心肺复苏与危重病实验室 重症医学二科
    2. 230601 合肥,安徽大学智能计算与信号处理教育部重点实验室
  • 收稿日期:2021-02-25 出版日期:2021-11-28
  • 通信作者: 杨旻
  • 基金资助:
    国家自然科学基金面上项目(82072134); 国家自然科学基金青年基金项目(81601661); 安徽医科大学校科研基金(2019xkj032)

Progress in septic cardiomyopathy from 2000 to 2020: analysis based on knowledge visualization

Wenyan Xiao1, Yu Liu2, Zongqing Lu1, Gan Tao1, Jin Zhang1, Yang Zhang1, Tianfeng Hua1, Min Yang1,()   

  1. 1. Department of Intensive Care Unit, Laboratory of Cardiopulmonary Resuscitation and Critical Care Medicine, the Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China
    2. Education Ministry of Key Laboratory of Intelligent Computing and Signal Processing, Anhui University, Hefei 230601, China
  • Received:2021-02-25 Published:2021-11-28
  • Corresponding author: Min Yang
引用本文:

肖文艳, 刘瑜, 陆宗庆, 陶干, 张金, 张洋, 华天凤, 杨旻. 2000年至2020年脓毒症心肌病领域的研究进展:基于知识可视化分析[J]. 中华重症医学电子杂志, 2021, 07(04): 331-338.

Wenyan Xiao, Yu Liu, Zongqing Lu, Gan Tao, Jin Zhang, Yang Zhang, Tianfeng Hua, Min Yang. Progress in septic cardiomyopathy from 2000 to 2020: analysis based on knowledge visualization[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2021, 07(04): 331-338.

目的

基于知识可视化分析,探讨2000年至2020年脓毒症心肌病(SCM)领域的研究进展。

方法

收集2000年1月1日至2020年12月20日中国知网(CNKI)及科学网(WOS)数据库收录的SCM研究领域相关文献。应用Excel软件对数据进行整理并绘制文献增长柱状图;应用CiteSpace 5.0 R1软件对国家、研究机构、作者信息进行提取及整理并生成相关共现网络,分析该领域主要研究力量分布及合作关系,对关键词及相关引文进行分析并绘制共被引文献网络,分析该领域前沿及热点信息。

结果

共收集中文文献774篇,英文文献1883篇,中文文献只进行研究机构、发文量、作者的统计描述,所有英文文献均纳入可视化分析。在发文量方面,2000年至2020年SCM研究领域相关国内外文献数量均呈迅速增长,英文文献数量多于中文文献。英文文献分析显示,全球发文量排名前3位的国家依次为美国(618篇)、中国(441篇)、德国(140篇)。从研究机构上看以武汉大学29篇位列WOS首位,德克萨斯大学与哈佛大学分别位列第2、3位;国内发文最多的研究机构为上海中医药大学(21篇)。作者共现网络分析显示在全球形成了四大科研团体,其中以Horton JW、Neviere R、Li CF和Thiemermann C对该领域贡献最大,其中中国学者在该领域研究势头强劲。关键词共现分析显示,研究热点主要围绕脓毒症患者的心功能及预后方面,而通过突增关键词分析可以看出国内文献更多地关注药物对SCM的治疗效果,而国外文献则更多地倾向对SCM的发病机制与管理方面的研究。共被引文献网络分析显示,未来对SCM的研究也应将从临床-机制-管理这几个方面着手,这也与突增关键词分析结果相吻合。

结论

通过知识可视化分析可以直观显示,SCM领域主要研究力量大多集中于美国、欧洲等发达国家,但中国学者势头强劲。未来研究趋势倾向于SCM的机制及治疗管理方面。

Objective

To investigate the research progress of septic cardiomyopathy from 2000 to 2020 based on knowledge visualization analysis.

Methods

The relevant literatures in septic cardiomyopathy were collected from Web of Science (WOS) and China National Knowledge Infrastructure(CNKI) database from 2000 to 2020. Excel 2019 software was used to show the growth trend of published number. CiteSpace 5.0 R1 software was used to extract and sort out the information of countries, institutions and authors, and then generate the relevant cooperative network, which shows the distribution and the major research forces. Meanwhile, keywords and the relevant reference were used to draw the co-cited literature network which reveals the frontier and hotpots in this field.

Results

A total of 774 Chinese and 1883 English were collected. In Chinese paper, only the number of published articles, authors and research institutions were statistically described, but all English literatures were included in visual analysis. The number of literatures related to septic cardiomyopathy at home and abroad increased rapidly from 2000 to 2020, and the number of English literatures was more than that of Chinese literatures. According to the analysis of English literature, the top three countries in the world were the United States (618 articles), China (441 articles) and Germany (140 articles). In terms of research institutions, Wuhan University ranked first with 29 papers, followed by Texas University and Harvard University. The research institution that published the most papers in Chinese was Shanghai University of Chinese Medicine (16 papers). According to the author's co-presentation network analysis, four major scientific research groups have been formed in the world, among which Horton JW, Neviere R, Li CF and Thiemermann C have made the largest contribution to this field which Chinese scholars also had a strong research momentum in this field. Keywords co-occurrence analysis, according to a research hotpot focused exclusively on the cardiac function and prognosis in patients with sepsis. Results of analysis of the exploding keywords revealed that the domestic literatures focus on drugs for sepsis cardiomyopathy management, while foreign literature focus on the pathogenesis of sepsis cardiomyopathy and management. Co-cited literature network analysis showed that future research on septic cardiomyopathy should also focus on the aspects of clinical-pathophysiological mechanism-management, which was consistent with the results of the bursting keywords analysis.

Conclusion

Knowledge visualization analysis show that the major research forces in septic cardiomyopathy are mostly concentrated in developed countries such as the United States and European countries, but Chinese scholars have a strong momentum. Future research trends tend to focus on the mechanism and treatment management of septic cardiomyopathy.

图1 2000年至2020年中国知网与科学网收录脓毒症心肌病领域的发文量变化趋势
表1 2000年至2020年科学网中脓毒症心肌病研究领域发文量前10位国家研究力量分布
表2 2000年至2020年科学网中脓毒症心肌病研究领域发文量前10位研究机构与作者的发文情况
表3 2000年至2020年中国知网中脓毒症心肌病研究领域发文量前10位研究机构与作者的发文情况
表4 2000年至2020年科学网中脓毒症心肌病研究领域前20位高频关键词与突增关键词分布
表5 2000年至2020年中国知网中脓毒症心肌病研究领域前10位高频关键词与突增关键词分布
图2 2000年至2020年科学网(Web of Science)中脓毒症心肌病研究领域文献共被引网络前10位大型聚类
表6 2000年至2020年科学网中脓毒症心肌病研究领域文献共被引网络前10位大型聚类情况
图3 2000年至2020年科学网中脓毒症心肌病研究领域共被引网络前10位大型聚类时间线注:从上到下即聚类按大小递减,从左到右即时间由远及近,在各个聚类横截面中,节点大小表示被引频次,节点越大,被引频次越多
表7 2000年至2020年科学网中脓毒症心肌病研究领域前10位高被引文献被引情况及所属聚类
1
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus defnitions for sepsis and septic shock(sepsis-3) [J]. JAMA, 2016, 5(8):801-810.
2
Vieillard-Baron A. Septic cardiomyopathy [J]. Ann Intensive Care, 2011, 1(1): 6.
3
Beesley SJ, Weber G, Sarge T, et al. Septic cardiomyopathy [J]. Crit Care Med, 2018, 46(4): 625-634.
4
李昕原, 吴彩军, 郭楠, 等. 脓毒症心肌病的研究进展 [J]. 中国中西医结合急救, 2019, 26(3): 372-377.
5
李玉婷, 李洪祥, 张东. 脓毒性心肌病的发病率及危险因素分析 [J]. 中华急诊医学, 2019, 28(7): 836-840.
6
刘长智, 朱瑞秋, 周柱江, 等. ECMO治疗脓毒症心肌病合并心源性休克 [J]. 中华危重病急救医学, 2017, 29(12): 1140-1143.
7
Ehrman RR, Sullivan AN, Favot MJ, et al. Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: a review of the literature [J]. Crit Care, 2018, 22(1): 112.
8
Ravikumar N, Sayed MA, Poonsuph CJ, et al. Septic cardiomyopathy: from basics to management choices [J]. Curr Probl Cardiol, 2020, 46(4): 100767.
9
Parker MM, Shelhamer JH, Bacharach SL, et al. Profound but reversible myocardial depression in patients with septic shock [J]. Ann Intern Med, 1984, 100(4): 483-490.
10
Stanzani G, Duchen MR, Singer M. The role of mitochondria in sepsis-induced cardiomyopathy [J]. Biochim Biophys Acta Mol Basis Dis, 2019, 1865(4): 759-773.
11
Liu YC, Yu MM, Shou ST, et al. Sepsis-induced cardiomyopathy: mechanisms and treatments [J]. Front Immunol, 2017, 8: 1021.
12
赵蓉英, 许丽敏. 文献计量学发展演进与研究前沿的知识图谱探析 [J]. 中国图书馆学报, 2010, 36(5): 60-68.
13
陆宗庆, 许耀华, 张金, 等, 2010至2020年ICU谵妄领域研究进展: 基于知识可视化分析 [J]. 中华危重病急救医学杂志, 2020, 32(7): 785-791.
14
陈超美, 陈悦, 侯剑华, 等. CiteSpace Ⅱ: 科学文献中新趋势与新动态的识别与可视化 [J]. 情报学报, 2009, 28(3): 401-421.
15
Joseph LC, Reyes MV, Lakkadi KR, et al. PKCδ causes sepsis-induced cardiomyopathy by inducing mitochondrial dysfunction [J]. Am J Physiol Heart Circ Physiol, 2020, 318(4): H778-H786.
16
Antonucci E, Fiaccadori E, Donadello K, et al. Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment [J]. J Crit Care, 2014, 29(4): 500-511.
17
L'Heureux M, Sternberg M, Brath L, et al. Sepsis-induced cardiomyopathy: a comprehensive review [J]. Curr Cardiol Rep, 2020, 22(5): 35.
18
Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 [J]. Intensive Care Med, 2013, 39(2): 165-228.
19
Landesberg G, Gilon D, Meroz Y, et al. Diastolic dysfunction and mortality in severe sepsis and septic shock [J]. Eur Heart J, 2012, 33(7): 895-903.
20
Lin H, Wang W, Lee M, et al. Current status of septic cardiomyopathy: basic science and clinical progress [J]. Front Pharmacol, 2020, 11: 210.
21
Kumar A, Haery C, Parrillo JE. Myocardial dysfunction in septic shock [J]. Crit Care Clin, 2000, 16(2): 251-287.
22
Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016 [J]. Crit Care Med, 2017, 45(3): 486-552.
23
Rudiger A, Singer M. Mechanisms of sepsis-induced cardiac dysfunction [J]. Crit Care Med, 2007, 35(6): 1599-1608.
24
Hou D, Bi X, Mao Z, et al. Biomaterials research of China from 2013 to 2017 based on bibliometrics and visualization analysis [J]. Peer J, 2019, 7: e6859.
[1] 韩媛媛, 热孜亚·萨贝提, 冒智捷, 穆福娜依·艾尔肯, 陆晨, 桑晓红, 阿尔曼·木拉提, 张丽. 组合式血液净化治疗对脓毒症患者血清炎症因子水平和临床预后的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 272-278.
[2] 孟建标, 张庚, 焦燕娜. 脓毒症合并心功能障碍患者早期肠道微生态改变的探讨[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 279-285.
[3] 陈宇, 冯芳, 张露, 刘健. 基于生物信息学分析筛选脓毒症心肌病关键致病基因[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 286-291.
[4] 莫小乔, 胡喆莹, 廖冬花, 谢天. 脓毒症继发急性肾损伤患者死亡风险预测模型构建及评估[J]. 中华危重症医学杂志(电子版), 2023, 16(03): 198-206.
[5] 作者. 脓毒症与脓毒性休克[J]. 中华危重症医学杂志(电子版), 2023, 16(03): 0-.
[6] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[7] 魏徐, 张鸽, 伍金林. 新生儿脓毒症相关性凝血病的监测和治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 379-386.
[8] 姚咏明. 如何精准评估烧伤脓毒症患者免疫状态[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 552-552.
[9] 江文诗, 何湘湘. 全球及我国器官捐献发展特征分析与学科建设[J]. 中华移植杂志(电子版), 2023, 17(05): 280-286.
[10] 窦上文, 邓欢, 刘邦锋, 岳高远志, 朱华财, 刘永达. 术前复查尿培养在预测微通道经皮肾镜取石术相关感染并发症中的作用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 361-366.
[11] 李伟, 卓剑, 黄川, 黄有攀. Lac、HO-1、sRAGE、CRP/ALB表达及脓毒症并发ARDS危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 514-516.
[12] 苗软昕, 乔晞. Toll样受体在脓毒症性急性肾损伤中的作用[J]. 中华肾病研究电子杂志, 2023, 12(04): 210-214.
[13] 李琪, 黄钟莹, 袁平, 关振鹏. 基于某三级医院的ICU多重耐药菌医院感染影响因素的分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 777-782.
[14] 谭睿, 王晶, 於江泉, 郑瑞强. 脓毒症中高密度脂蛋白、载脂蛋白A-I和血清淀粉样蛋白A的作用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(06): 749-753.
[15] 蔡荇, 郑瑞强. 肝素结合蛋白在脓毒症中的应用及研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(04): 487-490.
阅读次数
全文


摘要